Therapy Areas: AIDS & HIV
Spruce Biosciences names new vice president of Development Operations
18 July 2018 - Spruce Biosciences, a clinical-stage biotechnology company developing novel therapies for rare endocrine disorders, including its lead program for congenital adrenal hyperplasia (CAH), ...
Health Canada Grants Gilead Approval for Biktarvy for Treatment of HIV-1 Infection
16 July 2018 - - Mississauga, Ontario-based research biopharmaceutical company Gilead Canada, a subsidiary of global Gilead Sciences, Inc. (NASDAQ: GILD), was granted a notice of compliance by Health ...
CR Pharma to Market Ascletis Anti-Viral Ganovo in China
28 June 2018 - - Hangzhou, China-based biotechnology company Ascletis has signed a strategic cooperation agreement with CR Pharmaceutical Commercial Group to prepare for the launch of Ascletis' G...
Abivax names Scientific Advisory Board chair and new member
25 June 2018 - Abiwax (Paris:ABVX), a biotechnology company, announced on Friday the appointment of Professor Ian McGowan, MD, PhD, a current scientific advisory board (SAB) member, as chair of the SA...
Grifols wins new US FDA approval for the Procleix Ultrio Elite and Procleix WNV assays
20 June 2018 - Plasma medicine company Grifols (MCE:GRF) MCE:GRF.P) (NASDAQ:GRFS) disclosed on Tuesday the receipt of approval from the US Food & Drug Administration (FDA) for two blood screening ...
ViiV Healthcare reports two phase three trials assessing dolutegravir (Tivicay) and lamivudine (Epivir)
18 June 2018 - United Kingdom-based ViiV Healthcare has reported that two phase three trials assessing the two-drug regimen (2DR) of dolutegravir (Tivicay) and lamivudine (Epivir) in treatment naive H...